Cargando…

Criterion Validity of the “HRQOLISP-E”: A New Context-Specific Screening Tool for Poststroke Depression

OBJECTIVES: The optimal tool for identifying postsroke depression (PSD) is yet to be identified. In the present study, we rely on the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) as a meaningful criterion to investigate the psychometric properties of the HRQOLISP-E, a ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Ojagbemi, Akin, Owolabi, Mayowa, Akinyemi, Joshua, Ovbiagele, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660745/
https://www.ncbi.nlm.nih.gov/pubmed/29158623
http://dx.doi.org/10.1155/2017/6515769
_version_ 1783274347918524416
author Ojagbemi, Akin
Owolabi, Mayowa
Akinyemi, Joshua
Ovbiagele, Bruce
author_facet Ojagbemi, Akin
Owolabi, Mayowa
Akinyemi, Joshua
Ovbiagele, Bruce
author_sort Ojagbemi, Akin
collection PubMed
description OBJECTIVES: The optimal tool for identifying postsroke depression (PSD) is yet to be identified. In the present study, we rely on the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) as a meaningful criterion to investigate the psychometric properties of the HRQOLISP-E, a new context-specific screening tool for PSD developed from a large cross-cultural sample. METHODS: We assessed baseline data being collected as part of an intervention to improve one-year blood pressure control among recent (≤one month) stroke survivors. Depression was measured using the HADS-D and the HRQOLISP-E. We determined sensitivity, specificity, likelihood ratios, and posttest probability. The area under a receiver operator curve (AUC) and the most appropriate HRQOLISP-E cut-off were also determined using standard procedures. RESULTS: Using data derived from 387 recent stroke survivors, the HRQOLISP-E showed high agreement with the HADS-D, sensitivity = 73.7%, specificity = 79.3%, and posterior test probability = 88% (95% CI = 84%–91%). The AUC was 0.81 (95% CI = 0.76–0.86). The HRQOLISP-E cut-off, corresponding to HADS-D score ≥ 8, was 20/21 (out of a total score of 30). CONCLUSIONS: Within limitations of using the HADS-D as a referent criterion, the present results provide justification for further development of the HRQOLISP-E as the first stroke-specific screening tool for depression.
format Online
Article
Text
id pubmed-5660745
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-56607452017-11-20 Criterion Validity of the “HRQOLISP-E”: A New Context-Specific Screening Tool for Poststroke Depression Ojagbemi, Akin Owolabi, Mayowa Akinyemi, Joshua Ovbiagele, Bruce Behav Neurol Research Article OBJECTIVES: The optimal tool for identifying postsroke depression (PSD) is yet to be identified. In the present study, we rely on the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) as a meaningful criterion to investigate the psychometric properties of the HRQOLISP-E, a new context-specific screening tool for PSD developed from a large cross-cultural sample. METHODS: We assessed baseline data being collected as part of an intervention to improve one-year blood pressure control among recent (≤one month) stroke survivors. Depression was measured using the HADS-D and the HRQOLISP-E. We determined sensitivity, specificity, likelihood ratios, and posttest probability. The area under a receiver operator curve (AUC) and the most appropriate HRQOLISP-E cut-off were also determined using standard procedures. RESULTS: Using data derived from 387 recent stroke survivors, the HRQOLISP-E showed high agreement with the HADS-D, sensitivity = 73.7%, specificity = 79.3%, and posterior test probability = 88% (95% CI = 84%–91%). The AUC was 0.81 (95% CI = 0.76–0.86). The HRQOLISP-E cut-off, corresponding to HADS-D score ≥ 8, was 20/21 (out of a total score of 30). CONCLUSIONS: Within limitations of using the HADS-D as a referent criterion, the present results provide justification for further development of the HRQOLISP-E as the first stroke-specific screening tool for depression. Hindawi 2017 2017-10-11 /pmc/articles/PMC5660745/ /pubmed/29158623 http://dx.doi.org/10.1155/2017/6515769 Text en Copyright © 2017 Akin Ojagbemi et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ojagbemi, Akin
Owolabi, Mayowa
Akinyemi, Joshua
Ovbiagele, Bruce
Criterion Validity of the “HRQOLISP-E”: A New Context-Specific Screening Tool for Poststroke Depression
title Criterion Validity of the “HRQOLISP-E”: A New Context-Specific Screening Tool for Poststroke Depression
title_full Criterion Validity of the “HRQOLISP-E”: A New Context-Specific Screening Tool for Poststroke Depression
title_fullStr Criterion Validity of the “HRQOLISP-E”: A New Context-Specific Screening Tool for Poststroke Depression
title_full_unstemmed Criterion Validity of the “HRQOLISP-E”: A New Context-Specific Screening Tool for Poststroke Depression
title_short Criterion Validity of the “HRQOLISP-E”: A New Context-Specific Screening Tool for Poststroke Depression
title_sort criterion validity of the “hrqolisp-e”: a new context-specific screening tool for poststroke depression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660745/
https://www.ncbi.nlm.nih.gov/pubmed/29158623
http://dx.doi.org/10.1155/2017/6515769
work_keys_str_mv AT ojagbemiakin criterionvalidityofthehrqolispeanewcontextspecificscreeningtoolforpoststrokedepression
AT owolabimayowa criterionvalidityofthehrqolispeanewcontextspecificscreeningtoolforpoststrokedepression
AT akinyemijoshua criterionvalidityofthehrqolispeanewcontextspecificscreeningtoolforpoststrokedepression
AT ovbiagelebruce criterionvalidityofthehrqolispeanewcontextspecificscreeningtoolforpoststrokedepression